America Great Health
America Great Health operates as a biotechnology company in the United States. It focuses on the research and development of protein and peptide small molecular drugs; and manufacture and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and regenerative medicine and nutritional dietary supplements. The company was formerly known as Crown Marketing and changed its nam… Read more
America Great Health (AAGH) - Net Assets
Latest net assets as of March 2025: $-5.71 Million USD
Based on the latest financial reports, America Great Health (AAGH) has net assets worth $-5.71 Million USD as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($266.99K) and total liabilities ($5.98 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-5.71 Million |
| % of Total Assets | -2138.49% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
America Great Health - Net Assets Trend (2011–2025)
This chart illustrates how America Great Health's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for America Great Health (2011–2025)
The table below shows the annual net assets of America Great Health from 2011 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $-5.31 Million | -17.36% |
| 2024-06-30 | $-4.53 Million | 0.00% |
| 2023-06-30 | $-4.53 Million | -17.24% |
| 2022-06-30 | $-3.86 Million | -1695.51% |
| 2021-06-30 | $-215.01K | 0.00% |
| 2020-06-30 | $-215.01K | -27.98% |
| 2019-06-30 | $-168.00K | -56.35% |
| 2018-06-30 | $-107.45K | -123.55% |
| 2017-06-30 | $-48.07K | +95.60% |
| 2016-06-30 | $-1.09 Million | -10.17% |
| 2015-06-30 | $-992.37K | -336.64% |
| 2013-06-30 | $-227.27K | -284.56% |
| 2012-06-30 | $-59.10K | -1938.63% |
| 2011-06-30 | $-2.90K | -- |
Equity Component Analysis
This analysis shows how different components contribute to America Great Health's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1022468200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Comprehensive Income | $-1.48K | % |
| Other Components | $5.02 Million | % |
| Total Equity | $-5.23 Million | 100.00% |
America Great Health Competitors by Market Cap
The table below lists competitors of America Great Health ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MAS Gold Corp
PINK:MSGCF
|
$2.12 Million |
|
Orgabio Holdings Bhd
KLSE:0252
|
$2.12 Million |
|
PT Hetzer Medical Indonesia Tb
JK:MEDS
|
$2.12 Million |
|
Reliability Incorporated
PINK:RLBY
|
$2.12 Million |
|
Albion Resources Ltd
AU:ALB
|
$2.11 Million |
|
PT Hassana Boga Sejahtera Tbk
JK:NAYZ
|
$2.11 Million |
|
Exent Corp
PINK:EXNN
|
$2.11 Million |
|
TAKE-TWO INTERACT
BE:TKE
|
$2.11 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in America Great Health's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -4,451,133 to -5,231,105, a change of -779,972.
- Net loss of 1,220,571 reduced equity.
- Other comprehensive income decreased equity by 983.
- Other factors increased equity by 441,582.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.22 Million | -23.33% |
| Other Comprehensive Income | $-983.00 | -0.02% |
| Other Changes | $441.58K | +8.44% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares America Great Health's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-06-30 | $0.00 | $0.00 | x |
| 2012-06-30 | $0.00 | $0.00 | x |
| 2013-06-30 | $0.00 | $0.00 | x |
| 2014-06-30 | $0.00 | $0.00 | x |
| 2015-06-30 | $0.00 | $0.00 | x |
| 2016-06-30 | $0.00 | $0.00 | x |
| 2017-06-30 | $0.00 | $0.00 | x |
| 2018-06-30 | $0.00 | $0.00 | x |
| 2019-06-30 | $0.00 | $0.00 | x |
| 2020-06-30 | $0.00 | $0.00 | x |
| 2021-06-30 | $0.00 | $0.00 | x |
| 2022-06-30 | $0.00 | $0.00 | x |
| 2023-06-30 | $0.00 | $0.00 | x |
| 2024-06-30 | $0.00 | $0.00 | x |
| 2025-06-30 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently America Great Health utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -414.22%
- • Asset Turnover: 0.91x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-21.73K |
| 2012 | 0.00% | -1250.24% | 7.13x | 0.00x | $-50.35K |
| 2013 | 0.00% | -1641.77% | 0.33x | 0.00x | $-86.07K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-570.29K |
| 2015 | 0.00% | -35.87% | 1.79x | 0.00x | $84.22K |
| 2016 | 0.00% | -35.94% | 12.72x | 0.00x | $-1.03 Million |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-913.86K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-48.64K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-48.24K |
| 2020 | 0.00% | -948.41% | 1.41x | 0.00x | $-30.42K |
| 2021 | 0.00% | -948.41% | 1.41x | 0.00x | $-30.42K |
| 2022 | 0.00% | -4650.02% | 0.31x | 0.00x | $-4.49 Million |
| 2023 | 0.00% | -372.68% | 0.68x | 0.00x | $-316.31K |
| 2024 | 0.00% | -372.68% | 0.68x | 0.00x | $-316.31K |
| 2025 | 0.00% | -414.22% | 0.91x | 0.00x | $-697.46K |
Industry Comparison
This section compares America Great Health's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $197,918,388
- Average return on equity (ROE) among peers: -129.02%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| America Great Health (AAGH) | $-5.71 Million | 0.00% | N/A | $2.12 Million |
| Aadi Bioscience Inc (AADI) | $17.44 Million | -122.74% | 0.21x | $17.03 Million |
| Ascentage Pharma Group International (AAPG) | $274.16 Million | -147.88% | 8.55x | $2.25 Billion |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-27.92 Million | 0.00% | 0.00x | $54.18 Million |
| ABIVAX Société Anonyme (AAVXF) | $4.67 Million | -803.57% | 14.26x | $377.86 Million |
| Abcellera Biologics Inc (ABCL) | $1.23 Billion | 12.85% | 0.25x | $731.78 Million |
| Abeona Therapeutics Inc (ABEO) | $134.04 Million | -42.28% | 0.30x | $193.84 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $-18.59 Million | 0.00% | 0.00x | $102.67 Million |
| Abpro Holdings, Inc. (ABP) | $-14.95 Million | 0.00% | 0.00x | $2.00 Million |
| Absci Corp (ABSI) | $179.13 Million | -57.56% | 0.19x | $345.85 Million |